Sofosbuvir 400 mg

DRUG5 trials

Sponsors

Janssen Research & Development, LLC, Myanmar Oxford Clinical Research Unit, Eman Sayed Hassan Abd Allah, University of Dundee, Muhammad Radzi Abu Hassan

Conditions

Hepatitis CHepatitis C Virus

Phase 2

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

CompletedNCT02349048

Janssen Research & Development, LLCHepatitis C Virus

Start: 2015-01-31End: 2016-05-31Updated: 2017-03-01

A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study

CompletedNCT03236506

University of DundeeHepatitis C

Start: 2018-01-19End: 2020-10-28Updated: 2021-11-18

8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C

CompletedNCT04885855

Muhammad Radzi Abu HassanHepatitis C

Start: 2021-03-23End: 2024-03-15Updated: 2025-03-13

Unknown Phase

Hepatitis C Treatment Study in Myanmar

WithdrawnNCT03158857

Myanmar Oxford Clinical Research UnitHepatitis C

Start: 2022-01-31End: 2024-01-31Updated: 2021-12-17

Hepatitis c and Vitamin D and Iron Status

Eman Sayed Hassan Abd AllahHepatitis C

Start: 2017-06-30End: 2018-05-31Target: 87Updated: 2017-05-25

Related Papers

Time to viral load suppression with 8-week versus 12-week ravidasvir/sofosbuvir regimens among chronic hepatitis C patients in Malaysia: a non-inferiority, randomized clinical trial

BMC Infectious Diseases2026-06-11

Randomized clinical trial: Direct‐acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection

Journal of Viral Hepatitis2022-05-188 citations

P11 Impact of opiate substitution therapy on hepatitis C treatment oucomes for persons who inject drugs at injecting equipment provision sites in the advance HCV trial

Abstracts2020-09-011 citations

Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment—ADVANCE HCV protocol study

BMJ Open2019-08-0110 citations

Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for <scp>HCV</scp> genotype 1 infection

Journal of Viral Hepatitis2017-12-2412 citations